Suppr超能文献

裸盖菇素辅助疗法可能提升酒精使用障碍患者的保护价值观。

Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.

作者信息

Gold Noah D, Pagni Broc A, Petridis Petros D, Bogenschutz Michael P

机构信息

Department of Psychiatry, NYU Langone Center for Psychedelic Medicine, NYU Grossman School of Medicine, New York, New York, USA.

Albert Einstein College of Medicine, Bronx, New York, USA.

出版信息

Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):31-40. doi: 10.1089/psymed.2024.0030. eCollection 2025 Mar.

Abstract

BACKGROUND

Psilocybin can produce long-term changes in personality, personal values, and behavior. Although psilocybin-assisted therapy (PAT) is being actively studied for various psychiatric conditions, its effects on personal values in patients with alcohol use disorder (AUD) remain unexplored. This study examined the effects of PAT on personal values in patients with AUD and assessed relationships between value changes, acute psilocybin experiences, and drinking outcomes.

METHODS

In a phase II clinical trial (NCT02061293), 93 participants with AUD received 12 weeks of treatment, including manualized psychotherapy and two 8-h drug administration sessions with either psilocybin ( = 48) or active placebo ( = 45). Personal values were assessed before and after treatment using the Schwartz Value Survey (SVS), which includes 4 domain scores (Openness to Change, Self-Enhancement, Conservation, Self-Transcendence) and 10 subscales. The acute psychedelic experience was measured using the 30-item Mystical Experience Questionnaire (MEQ) and the 5-Dimensional Altered States of Consciousness Scale (5D-ASC). Treatment effects were assessed using univariate ANCOVAs, with baseline SVS values as covariates. Time effects within each group were evaluated using paired -tests. Pearson correlations examined the relationship between value changes and acute effects, and also value changes and drinking outcomes.

RESULTS

Significant treatment effects were detected for the Conservation domain and its subscales "security" and "tradition." No other domains or subscales showed significant treatment effects. Within the psilocybin group, time effects were significant only for conservation, and its subscales "tradition," and "security". No significant time effects were detected in the placebo group. In the psilocybin group, the MEQ subscale Ineffability was significantly associated with increases in Conservation, "security," and "tradition" ( = 0.31-0.34). 5D-ASC subscale Vigilance Reduction was associated with Conservation ( = 0.31), but not its subscales. 5D-ASC subscale Dread of Ego Dissolution during the psilocybin sessions correlated with increases in "tradition" ( = 0.31). None of the value changes were significantly associated with drinking outcomes.

CONCLUSION

PAT may alter value structure in patients with AUD patients by increasing Conservation. Although some associations were found between acute psychedelic effects and changes in Conservation, these value changes were not related to drinking outcomes.

摘要

背景

裸盖菇素可引起人格、个人价值观和行为的长期变化。尽管裸盖菇素辅助治疗(PAT)正在针对各种精神疾病进行积极研究,但其对酒精使用障碍(AUD)患者个人价值观的影响仍未得到探索。本研究考察了PAT对AUD患者个人价值观的影响,并评估了价值观变化、急性裸盖菇素体验与饮酒结果之间的关系。

方法

在一项II期临床试验(NCT02061293)中,93名AUD参与者接受了为期12周的治疗,包括标准化心理治疗以及两次8小时的药物给药疗程,分别使用裸盖菇素(n = 48)或活性安慰剂(n = 45)。治疗前后使用施瓦茨价值调查(SVS)评估个人价值观,该调查包括4个领域得分(对变化的开放性、自我提升、保守主义、自我超越)和10个分量表。使用30项神秘体验问卷(MEQ)和5维意识改变状态量表(5D-ASC)测量急性迷幻体验。使用单变量协方差分析评估治疗效果,以基线SVS值作为协变量。使用配对t检验评估每组内的时间效应。Pearson相关性检验考察了价值观变化与急性效应之间的关系,以及价值观变化与饮酒结果之间的关系。

结果

在保守主义领域及其“安全”和“传统”分量表中检测到显著的治疗效果。其他领域或分量表未显示出显著的治疗效果。在裸盖菇素组中,仅保守主义及其“传统”和“安全”分量表的时间效应显著。在安慰剂组中未检测到显著的时间效应。在裸盖菇素组中,MEQ分量表“不可言喻性”与保守主义、“安全”和“传统”的增加显著相关(r = 0.31 - 0.34)。5D-ASC分量表“警惕性降低”与保守主义相关(r = 0.31),但与其次级量表无关。裸盖菇素疗程中5D-ASC分量表“对自我解体的恐惧”与“传统”的增加相关(r = 0.31)。没有任何价值观变化与饮酒结果显著相关。

结论

PAT可能通过增加保守主义来改变AUD患者的价值结构。尽管在急性迷幻效应与保守主义变化之间发现了一些关联,但这些价值观变化与饮酒结果无关。

相似文献

1
Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):31-40. doi: 10.1089/psymed.2024.0030. eCollection 2025 Mar.
2
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
3
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530.
2
Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences.
Front Psychol. 2023 Jun 14;14:1104627. doi: 10.3389/fpsyg.2023.1104627. eCollection 2023.
3
A Systematic Approach to Standardizing Drinking Outcomes From Timeline Followback Data.
Subst Abuse. 2023 Mar 11;17:11782218231157558. doi: 10.1177/11782218231157558. eCollection 2023.
4
Personal Values and Substance Use in Adolescence and Young Adulthood: Risk or Protective Factors?
Subst Use Misuse. 2023;58(2):171-179. doi: 10.1080/10826084.2022.2151312. Epub 2022 Dec 20.
5
Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.
Contemp Clin Trials. 2022 Dec;123:106976. doi: 10.1016/j.cct.2022.106976. Epub 2022 Nov 2.
6
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443.
8
Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.
Front Psychiatry. 2022 Jul 12;13:917199. doi: 10.3389/fpsyt.2022.917199. eCollection 2022.
9
Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions.
Front Psychol. 2022 Jun 10;13:887255. doi: 10.3389/fpsyg.2022.887255. eCollection 2022.
10
Registered clinical studies investigating psychedelic drugs for psychiatric disorders.
J Psychiatr Res. 2021 Jul;139:71-81. doi: 10.1016/j.jpsychires.2021.05.019. Epub 2021 May 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验